相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥4900.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥2045.0 |
| 规格: | 5 mg | 产品价格: | ¥4500.0 |
| 规格: | 10 mg | 产品价格: | ¥8000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
TMP778
CAS No. : 1422053-04-0
MCE 国际站:TMP778
产品活性:TMP778 是一种有效的、RORγt 的选择性逆向激动剂,其 FRET 检测出的 IC50 值为 7 nM。
研究领域:Metabolic Enzyme/Protease | Vitamin D Related/Nuclear Receptor
作用靶点:ROR
In Vitro: It is found that TMP778 at >2.5 μM starts to show toxic effects on cell growth, which however is not RORγt-dependent, since the proliferation of RORγt-deficient T cells cultured under Th17 cell-polarizing conditions is also decreased. Otherwise, these inhibitors do not show inhibitory effects on cell proliferation or RORγt expression or its nuclear translocation, but efficiently inhibited IL-17 production. TMP778 has a much broader dose range and efficiently decreased IL-17 production, consistent with its higher binding affinity for RORγt. These data indicate that TMP778 is the RORγt inhibitor that most potently reduced IL-17 production.
In Vivo: All three compounds (e.g., TMP778) delay the onset of disease and substantially reduce the severity of disease progression compared to control-treated mice. Consistent with in vitro results, TMP778 treatment causes the most pronounced effect on the disease phenotype. This treatment not only decreases the number of mononuclear cells infiltrating the central nervous system (CNS), but also most strongly reduces the percentage of IL-17+ T cells in the CNS (including IL-17+ IFNγ+). There is no significant change in the percentage IFNγ+ IL-17-T cells in the CNS among all groups, indicating that none of the inhibitors affects Th1 responses. TMP778 strongly inhibits Th17 cell generation, reduces IL-17 production from differentiated Th17 cells, and also dramatically ameliorates the progression of EAE.
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Small Molecule Immuno-Oncology Compound Library | Transcription Factor-Targeted Library | Nuclear Receptor Compound Library | Heterocyclic Compound Library | T0901317 | Nobiletin | SR1078 | 3-Oxo-5β-cholanoic acid | SR3335 | GSK805 | SR1001 | Zilovertamab | Cintirorgon | SR2211 | XY018 | GSK2981278 | Neoruscogenin | PF-06747711 | SR0987 | TMP920 | Cedirogant | AZD-0284 | GNE-6468 | JNJ-61803534 | RORγt inverse agonist 13 | 7ß,27-Dihydroxycholesterol | GNE-0946 | S18-000003 | Vimirogant hydrochloride | XY101 | Bevurogant | MRL-871 | RORγt agonist 3 | RORγt Inverse agonist 10
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验磺胺药物是重要的广适性的抗生(抗菌)药物。它们都含有对氨基苯磺酰胺基团,故称为磺胺类药物。它不仅能局部外用,而且可内服,预防和治疗局部和全身细菌感染,如肺炎、脑膜炎、败血症等。目前常用的磺胺药有磺胺嘧啶( SD ) 和磺胺甲基异噁唑( SMZ ) 。若分子中酰胺基的一个氢被甲氧吡嗪 基团取代便成为长效磺胺。若被 5 , 6- 二甲氧基嘧啶 取代,其药效可增长至 150h (半衰期)。人们还发现了若把广谱增效剂——甲氧苄氨嘧啶( TMP )与磺胺
【求助】最近在做hsv tk,所用前药为粉末状GCV(购自sigma),但不知道怎么溶解
at 2-8 °C. Under these conditions the product is stable for 3 years. 说明书: http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product_Information_Sheet/2/g2536pis.Par.0001.File.tmp/g2536pis.pdf qulinyd 谢谢楼上,主要是我想用来做细胞实验,担心hcl会不会有影响,或者会
Mixed Infections with Rotaviruses: Protocols for Reassortment, Complementation, and Other Assays
of the interactions. Here, methods for mixed infections between conditional-lethal mutants of the temperature-sensitive (ts ) phenotype will be presented and considered. (Mutants with ts phenotype are designated according to the following nomenclature: ts A [778
技术资料暂无技术资料 索取技术资料

















